- Home
- WHLR vs GTBP Comparison
WHLR vs GTBP Comparison
Compare WHLR & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WHLR | GTBP |
|---|---|---|
| Founded | 2011 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 2.6M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | WHLR | GTBP |
|---|---|---|
| Price | $2.73 | $0.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.1M | 1.6M |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 61.36 | N/A |
| Revenue | ★ $101,834,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.05 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.62 | $0.54 |
| 52 Week High | $9,590.00 | $4.10 |
Technical Indicators
Market Signals| Indicator | WHLR | GTBP |
|---|---|---|
| Relative Strength Index (RSI) | 47.64 | 44.62 |
| Support Level | $2.62 | $0.58 |
| Resistance Level | $6.85 | $0.82 |
| Average True Range (ATR) | 0.81 | 0.07 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 25.09 | 20.15 |
Price Performance
Historical ComparisonAbout WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.